← Eichor
Study identifier: NCT06038227 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lung cAncer Robotic Comparative Study

Condition: Lung Cancer  ·  Sponsor: Intuitive Surgical

PhaseN/A
Planned participants512
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Marie Allouis  ·  +33786480495  ·  Marie.Allouis@intusurg.com

James Grainger  ·  james.grainger@intusurg.com

Always discuss trial participation with your own doctor first.

Locations (12)

Copenhagen University Hospital RigshospitaletCopenhagen, DenmarkRecruiting
AP-HMMarseille, FranceRecruiting
CHU de RouenRouen, FranceRecruiting
CHU de ToulouseToulouse, FranceRecruiting
ThoraxklinikHeidelberg, GermanyRecruiting
Krankenhaus Barmherzige BrüderRegensburg, GermanyRecruiting
Azienda Ospedaliero Universitaria PisanaPisa, ItalyRecruiting
Akershus University HospitalLoerenskog, NorwayRecruiting
University Hospitals Bristol and Weston NHS Foundation TrustBristol, United KingdomRecruiting
University Hospitals Coventry and Warwickshire NHS TrustCoventry, United KingdomRecruiting
Guy's and St Thomas' NHS Foundation TrustLondon, United KingdomRecruiting
St Bartholomew HospitalLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06038227